Why the study?
Established risk scores are not validated for elderly TAVR cohorts, making periprocedural risk stratification difficult, and serum albumin might help estimate morbidity and mortality.
Does preoperative low serum albumin predict higher postoperative complications and early mortality in patients undergoing TAVR?
Population
457 patients with severe symptomatic aortic stenosis undergoing TAVR
Comparison
Preoperative low serum albumin (<3.5 g/dL) vs normal serum albumin (≥3.5 g/dL)
Design
Single-center retrospective study
Follow-up
30 days
Authors
Loading...
Low albumin may flag frailty-related risk in TAVR; hypothesis-generating and requires prospective validation before clinical use.
Does preoperative low serum albumin predict higher postoperative complications and early mortality in patients undergoing TAVR?
Preoperative low serum albumin is a simple, objective marker that predicts higher morbidity and 30-day mortality in elderly patients undergoing TAVR.
Gassa et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: